Extendible stent apparatus

Information

  • Patent Grant
  • 8241349
  • Patent Number
    8,241,349
  • Date Filed
    Thursday, February 3, 2011
    13 years ago
  • Date Issued
    Tuesday, August 14, 2012
    12 years ago
Abstract
The present invention concerns novel stent apparatuses for use in treating lesions at or near the bifurcation point in bifurcated cardiac, coronary, renal, peripheral vascular, gastrointestinal, pulmonary, urinary and neurovascular vessels and brain vessels. More particularly, the invention concerns a stent apparatus with at least one side opening which may further comprise an extendable stent portion laterally extending from the side opening and at least partly in registry with the wall of the side opening. Devices constructed in accordance with the invention include, singularly or in combination, a main expandable stent comprising at least one substantially circular side opening located between its proximal and distal end openings, which side opening may further comprise an expandable portion extending radially outward from the edges of the side opening; and a branch stent comprising proximal and distal end openings and which may further comprise a contacting portion at its proximal end, and which may optionally be constructed to form either a perpendicular branch or a non-perpendicular branch when inserted through a side opening of the main stent. The stents of the invention are marked with, or at least partially constructed of, a material which is imagable during intraluminal catheterization techniques, most preferably but not limited to ultrasound and x-ray.
Description
BACKGROUND OF THE INVENTION

A type of endoprosthesis device, commonly referred to as a stent, may be placed or implanted within a vein, artery or other tubular body organ for treating occlusions, stenoses, or aneurysms of a vessel by reinforcing the wall of the vessel or by expanding the vessel. Stents have been used to treat dissections in blood vessel walls caused by balloon angioplasty of the coronary arteries as well as peripheral arteries and to improve angioplasty results by preventing elastic recoil and remodeling of the vessel wall. Two randomized multicenter trials have recently shown a lower restenosis rate in stent treated coronary arteries compared with balloon angioplasty alone (Serruys, P W et al. New England Journal of Medicine 331: 489-495, 1994, Fischman, D L et al. New England Journal of Medicine 331: 496-501, 1994). Stents have been successfully implanted in the urinary tract, the bile duct, the esophagus and the tracheo-bronchial tree to reinforce those body organs, as well as implanted into the neurovascular, peripheral vascular, coronary, cardiac, and renal systems, among others. The term “stent” as used in this Application is a device which is intraluminally implanted within bodily vessels to reinforce collapsing, dissected, partially occluded, weakened, diseased or abnormally dilated or small segments of a vessel wall.


One of the drawbacks of conventional stents is that they are generally produced in a straight tubular configuration. The use of such stents to treat diseased vessels at or near a bifurcation (branch point) of a vessel may create a risk of compromising the degree of patency of the primary vessel and/or its branches, or the bifurcation point and also limits the ability to insert a second stent into the side branch if the result of treatment of the primary, or main, vessel is suboptimal. Suboptimal results may occur as a result of several mechanisms, such as displacing diseased tissue, plaque shifting, vessel spasm, dissection with or without intimal flaps, thrombosis, and embolism.


The risk of branch compromise is increased generally in two anatomical situations. First, a side branch may be compromised when there is a stenosis in the origin of the side branch. Second, when there is an eccentric lesion at the bifurcation site, asymmetric expansion can cause either plaque shifting or dissection at the side branch origin. There are reports of attempts to solve this problem by inserting a balloon into the side branch through the struts of a stent deployed in the main branch spanning the bifurcation point; however, this technique carries the risk of balloon entrapment and other major complications (Nakamura, S. et al., Catheterization and Cardiovascular Diagnosis 34: 353-361 (1995)). Moreover, adequate dilation of the side branch is limited by elastic recoil of the origin of the side branch. In addition, insertion of a traditional stent into a main vessel spanning the bifurcation point may pose a limitation to blood flow and access to the side branch vessel. The term “stent jail” is often used to describe this concept. In this regard, the tubular slotted hinged design of the Palmaz-Schatz intracoronary stent, in particular, is felt to be unfavorable for lesions with a large side branch and is generally believed to pose a higher risk of side branch vessel entrapment where the stent prevents or limits access to the side branch. Id.


One common procedure for intraluminally implanting a stent is to first open the relevant region of the vessel with a balloon catheter and then place the stent in a position that bridges the treated portion of the vessel in order to prevent elastic recoil and restenosis of that segment. The angioplasty of the bifurcation lesion has traditionally been performed using the “kissing” balloon technique where two guidewires and two balloons are inserted, one into the main branch and the other into the side branch. Stent placement in this situation requires the removal of the guidewire from the side branch and reinsertion through the stent struts, followed by the insertion of a balloon through the struts of the stent along the guidewire. The first removal of the guidewire poses the risk of occlusion of the side branch during the deployment of the stent in the main branch.


In general, when treating a bifurcation lesion using commercially available stents, it is important to cover the origin of the branch because if left uncovered, this area is prone to restenosis. In order to cover the branch origin, conventional stents inserted into the branch must protrude into the lumen of the main artery or vessel from the branch (which may cause thrombosis, again compromising blood flow). Another frequent complication experienced when stenting bifurcated vessels is the narrowing or occlusion of the origin of a side branch spanned by a stent placed in the main branch. Additionally, placement of a stent into a main vessel where the stent partially or completely extends across the opening of a branch makes future access into such branch vessels difficult if not impossible. As a result, conventional stents are often placed into the branch close to the origin, but generally not covering the origin of the bifurcation.


Lastly, conventional stents are difficult to visualize during and after deployment, and in general are not readily imaged by using low-cost and easy methods such as x-ray or ultrasound imaging. While some prior art balloon catheters (and not stents) are “marked” at the proximal and distal ends of the balloon with imagable patches, few stents are currently available which are marked with or which are at least partly constructed of, a material which is imagable by currently known imaging procedures commonly used when inserting the stents into a vessel, such as ultrasound or x-ray imaging. The invention described in this Application would not work with endoscopy as currently used as an imaging method due to size limitations, but future advances in limiting the size of endoscopic imaging devices may in the future make endoscopic imaging compatible with the stents of the invention.


Accordingly, there is a need for improved stent apparatuses, most particularly for applications within the cardiac, coronary, renal, peripheral vascular, gastrointestinal, pulmonary, urinary and neurovascular systems and the brain which 1) completely covers the bifurcation point of bifurcation vessels; 2) may be used to treat lesions in one branch of a bifurcation while preserving access to the other branch for future treatment; 3) allows for differential sizing of the stents in a bifurcated stent apparatus even after the main stent is implanted; 4) may be delivered intraluminally by catheter; 5) may be used to treat bifurcation lesions in a bifurcated vessel where the branch vessel extends from the side of the main vessel; and 6) is marked with, or at least partly constructed of, material which is imagable by commonly used intraluminal catheterization visualization techniques including but not limited to ultrasound or x-ray.


SUMMARY OF THE INVENTION

The present invention concerns novel stent apparatuses for methods, and kits use in treating lesions at or near the bifurcation point in bifurcated vessels. More particularly, the invention concerns a stent apparatus with a main tubular stent body having at least one side opening which may further comprise an extendable or second stent inserted through the side opening and at least partly in registry with the wall of the side opening.


As used herein, the term “vessel” means any body lumen or tubular tissue within the cardiac, coronary, renal, peripheral vascular, gastrointestinal, pulmonary, urinary and neurovascular systems and the brain. Devices constructed in accordance with the invention include, singularly or in combination, a main expandable tubular stent body having at least one side opening (usually substantially circular) located between its proximal and distal end openings, which side opening may further comprise a radially expandable portion extending laterally outward from the edges of the side opening; and an expandable branch second stent comprising proximal and distal end openings and which may further comprise a contacting portion at its proximal end, and which may be constructed to form an angularly variable branched stent apparatus when inserted through a side opening of the main stent. The radially expandable portion preferably comprises a plurality of laterally deployable elements, such as loops, tabs, beams, or the like, attached or coupled to a peripheral edge of the side opening. Usually, the elements will project inwardly from the periphery into the side hole so that they may be deployed radially outwardly from the periphery to open in a petal-like fashion. The elements may be formed integrally as part of the tubular body structure, e.g., being formed from the bent wire or band or from the cut tubular structure which defines the stent structure. Alternatively, they could be formed separately and subsequently attached by crimping, welding, folding, interference fitting, etc. Optionally, the expandable portion may be covered with a fabric or the entire stent structure membrane to help form the transition between the main body lumen and the lumen of the second stent. The stents of the invention are marked with, or at least partially constructed of, a material which is imagable during intraluminal catheterization techniques, most preferably but not limited to ultrasound and x-ray, preferably being radiopaque.


In a preferred aspect of the stent design, the side hole will be defined by a continuous band or pattern of material which defines the periphery of the side hole. The band may have a circular, oval, or other regular geometry in which case the width and area of the side hole will remain generally constant as the stent is expanded. Alternatively, the continuous band may comprise discontinuities over its length so that the area and/or width of the side hole may expand together with the stent structure. Preferably, the continuous band will include inwardly projecting loops, fingers, or other protrusions which will define the laterally deployable elements which project inwardly from the peripheral edge of the side opening. The inwardly projecting loops or other elements may be overlapping or non-overlapping. The use of overlapping looped structures maximizes the length of the inwardly projecting elements after they are unfolded and opened inwardly into the side branch, as described in more detail below.


In another aspect of the present invention, a stent for placement in a bifurcated body lumen comprises a main tubular body having a first end, a second end, and a side opening therebetween. A first portion of the main tubular body between the first end and the side hole opens in response to a first radially outward pressure, typically provided by an expansion balloon. A second portion of the main tubular body between the side hole and the second end opens in response to a second pressure, again typically applied by an expansion balloon. By constructing the main tubular body so that the first opening pressure is less than the second opening pressure, the stent can have differential opening characteristics. That is, by introducing a balloon expansion catheter into the stent and applying a constant pressure over the entire length of the balloon, the first portion of the stent will yield and open before the second portion of the stent. The particular embodiments described below, the first yield pressure will typically be in the range from 1 atmospheres to 10 atmospheres while the second yield pressure will typically be in the range from 2 atmospheres to 18 atmospheres. Such stent structures may be placed by initially opening and deploying the first portion, typically the proximal portion on the same side of the bifurcation as the deployment catheter, and thereafter positioning the side hole to align more precisely with the bifurcated secondary blood vessel. After the proper positioning has been achieved, the second stent portion can then be opened, conveniently using the same expansion balloon which has been inflated to a higher inflation pressure. Such stents will typically include the laterally deployable elements disposed around the side opening, as described above, and will optionally be used in combination with secondary stents, as described above.


The stent structures as described previously may combine conventional stent elements, such as serpentine rings, diamond or box structures, axial expansion members, and the like. In addition, in order to provide the differential expansion characteristics, the main tubular bodies of the stents may include axial spine structures which differ from the remaining portions of the tubular body of the stent. For example, the first portion of the stent may have an axial spine which readily expands circumferentially. By then providing a spine section on the second portion of the stent which is more resistant to circumferential expansion, the desired differential expansion will be achieved. Alternatively, the differential expansion can be achieved by employing stent patterns which are uniformly easier or more difficult to radially expand over their entire peripheral length. Specific examples of both structures will be described below.


The stent apparatuses of the invention offers significant and novel advantages over prior art stents in that the stents of the invention 1) can completely cover the bifurcation point of a branched vessel; 2) can accommodate main and branch stents of differing sizes, thus providing a better fit where the main and branch vessels are of different sizes or where the main and branch vessels are occluded to different degrees; 3) can fit branched vessels where the branch extends laterally from the side of the main vessel; 4) may be used to treat lesions in one branch of a bifurcation while preserving complete access to the other branch for future treatment; 5) may be delivered intraluminally by catheter; and 6) are marked with, or at least partly constructed of, material which is imagable by commonly used intraluminal catheterization visualization techniques including but not limited to ultrasound or x-ray, but not endoscopy.


Thus, it is an object of the present invention to provide both a double-stent apparatus and a single-stent apparatus, each of which may be used to cover the origin of a bifurcation in a branched vessel.


Another object of the invention is to provide a single-stent apparatus which may be used to treat only one branch of a bifurcation lesion while leaving access to the second branch unobstructed.


Additionally, it is an object of the invention to provide a stent apparatus which is itself imagable by methods commonly used during catheterization such as x-ray or ultrasound.


Yet another object of the invention is to provide a bifurcating double-stent device wherein the main stent and the branch stent or stents may be of different sizes.


Lastly, it is an important object of the invention to provide a stent apparatus which may be used to treat bifurcated vessels where the vessel bifurcation extends laterally from the side of the main vessel.


These objects and other object advantages and features of the invention will become better understood from the detailed description of the invention and the accompanying drawings.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic depiction of the double-stent apparatus of the present invention in which both the main stent and the branch stent are fully dilated.



FIG. 2 is a schematic depiction of the main stent of the apparatus of the invention as deployed, with the side opening in registry with a vessel bifurcation point.



FIG. 3 is a schematic depiction of the branch stent of the apparatus as deployed, with the contacting portion fully expanded to contact the origin of the bifurcated vessel.



FIG. 4 is a schematic depiction of the main stent of the apparatus deployed within a subject vessel, after inflation of a balloon to expand the main stent to fit the walls of the subject vessel.



FIG. 5 is a schematic depiction of the double-stent bifurcating stent apparatus, where the main stent is deployed and showing the placement of the branch stent apparatus prior to full deployment of the branch stent.



FIG. 6
a depicts initial placement of the main stent of the bifurcating stent apparatus into the vessel, along with the insertion of a guidewire and stabilizing catheter for placement of the branch stent into the branch vessel of the subject.



FIG. 6
b is a schematic depiction showing the main stent of the invention expanded by balloon expansion.



FIG. 6
c is a schematic depiction of the deployment of the branch stent over the side branch guidewire, through one of the side openings in the main stent and into the branch vessel of the subject.



FIG. 6
d is a schematic depiction of the removal of the protective sheath of the branch stent allowing for full expansion of the contacting portion prior to final placement and deployment.



FIG. 6
e is a schematic depiction of the compressed branch stent positioned into the branch by the catheter with the contacting portion at least partly contacting the side opening in the main stent, but prior to full expansion of the branch stent.



FIG. 6
f is a schematic depiction of the fully expanded main stent and the fully positioned and expanded branch stent, where the branch stent is being dilated by inflation of a balloon.



FIG. 6
g is a schematic depiction of the fully expanded bifurcating double stent of the invention, positioned into the bifurcation point in a subject vessel.



FIG. 7 is a schematic depiction of the main stent with optional expandable portion, prior to balloon expansion of the expandable portion.



FIG. 8 is a schematic depiction of balloon expansion of the optional expandable portion of the main stent to cover a vessel bifurcation point.



FIG. 9 is a schematic depiction of the main stent with the optional expandable portion fully expanded to extend laterally from the side opening of the main stent.



FIG. 10 illustrates a first stent pattern having a side hole and differential expansion characteristics in a “rolled out” view.



FIG. 11 illustrates a second stent pattern having a side hole and differential expansion characteristics in a “rolled out” view.



FIG. 12 illustrates a third stent pattern having a side hole and differential expansion characteristics in a “rolled out” view.



FIGS. 13A-13H illustrate the deployment of any one of the stents of FIGS. 10-12 in a bifurcated blood vessel or a secondary stent is placed through the side hole of the main stent.



FIG. 14A illustrates a fourth stent pattern having a side hole and differential expansion characteristics in a “rolled out” view.



FIG. 14B shows a stent of FIG. 14A with first portion 804 protruding outwardly as a flap during stent expansion.



FIG. 15 illustrates a fifth stent pattern having a side hole and differential expansion characteristics in a “rolled out” view.



FIG. 16 illustrates a sixth stent pattern having a side hole and differential expansion characteristics in a “rolled out” view.



FIG. 17 illustrates a seventh stent pattern having a side hole and differential expansion characteristics in a “rolled out” view.





The rectilinear matrices shown in the drawings are intended to show the shapes of the surfaces only, and do not illustrate the actual surface patterns or appearances of the stent apparatuses of the invention.


DESCRIPTION OF THE SPECIFIC EMBODIMENTS

The bifurcating double-stent apparatus 10 of the present invention comprises a generally cylindrical main stent 12 and a generally cylindrical branch stent 15, which are shown as fully dilated in a subject main vessel 8 and a subject branch vessel 7, as illustrated in FIG. 1.


The main stent 12 contains at least one generally circular side opening 16 located between the proximal end 26 and the distal end 28 of the main stent 12 (FIG. 2), which opening is positioned over and in registry with the opening 48 of a branch vessel in a vessel bifurcation 50, as shown in FIG. 2. The stent 12 and the side opening are imaged during imaging procedures either by constructing the stent of imagable materials or by placing markers 56 at appropriate locations, such as around the perimeter of the side opening 16 in the main stent 12, and at the proximal end 26 and distal end 28 of the main stent, as illustrated in FIG. 4.


As shown in the embodiment of the invention illustrated in FIG. 4, a guidewire 20 is inserted into the vessel 8 prior to insertion of the main stent 12, and is used to guide the main stent 12 into position within the vessel 8. Prior to insertion and expansion, the main stent 12 is disposed around the distal end of a catheter 48 which may include an inflatable balloon 24. The main stent/catheter apparatus is then threaded onto the main guidewire 20 and into the vessel 8. The main stent 12 is radially expanded by inflation of the balloon 24 until it expands the walls of the vessel 8, and is thus affixed into place.


In a second embodiment of the invention, the branch stent apparatus 15 of the present invention comprises a generally cylindrical stent comprising a proximal end 30 and a distal end 32, as shown in FIG. 3. The proximal end 30 comprises a contacting portion illustrated here as extended loops 18, which contacting portion, when expanded, is positioned within the lumen 58 of the main vessel 8 (FIG. 3) and at least partially contacting the perimeter of the side opening 16 of the main stent 12. FIG. 4 illustrates the positioning of the main stent 12 (without optional contacting portion) in the main vessel 8 as fully expanded by inflation of the balloon 24.


As shown in the embodiments illustrated in FIGS. 4, 5 and 7, the ends of the main stent 12 and the expandable branch stent 15 and the contacting portion 18 are visible during insertion by placing imagable markers 56 around the ends of the main 12 and branch 15 stents and the contacting portion 18 and at the proximal end 30 and distal end 32 of the branch stent. Alternatively, the stent may be at least partially constructed of material which is imagable by methods including but not limited to ultrasound or x-ray imaging (but not endoscopic imaging).


As shown in yet another embodiment, the stents of the invention are combined to form a bifurcating double stent as illustrated in FIGS. 5 and 6a-g. After insertion of the main stent as described above but prior to expansion of the main stent (FIG. 6a), the branch stent 15 is inserted through a side opening 16 of the main stent 12, a guidewire 36 and a stabilizing catheter 44 are inserted through the side opening 16 in the main stent 12, and into a branch vessel 7 (FIG. 6a). The stabilizing catheter 44 is used to place the side opening 16 in the main stent 12 over the bifurcation point 50 in the bifurcated vessels 7 and 8 (FIG. 6a). In the embodiment depicted here, the main stent is then deployed into position by inflation of the balloon 24 (FIG. 6b). During insertion and prior to dilation of the branch stent, the branch stent 15 is disposed around the distal end of a branch catheter 54 which may optionally include an inflatable balloon 25, and the contacting portion 18 of the branch stent 15 is held in a collapsed position by a protective sheath 34, as shown in FIG. 6c.


In the bifurcating double-stent apparatus 10 of the invention, once the main stent 12 is dilated and the stabilizing catheter 44 (as shown in FIG. 6b) is removed, the branch stent 15 is inserted over the branch guidewire 36 and through the opening 16 of the main stent 12 substantially as shown in FIG. 6c, and affixed in place by withdrawal of the protective sheath 34 (FIG. 6d) and insertion of the branch stent 15 until it at least partially contacts the perimeter of the opening 16 of the main stent 12 by the expansion of the contacting portions 18 which are positioned at the proximal end 30 of the expandable stent, as shown in FIG. 6e. The branch stent 15, once positioned in the branch vessel 7, may be then fully expanded by the balloon 25, as shown in FIG. 6f. The angle at which the optionally expandable branch stent 15 is affixed depends upon the vessel structure into which the bifurcating stent apparatus 10 is inserted. All catheters, and guidewires are then withdrawn from the subject vessels, leaving the main stent 12 through which the branch stent 15 is inserted into the branch vessel 7, forming a bifurcated stent 10 (FIG. 6g).


As illustrated in FIGS. 6a-6g, the main stent 12 is deployed prior to the branch stent 15. This is the presently preferred order of deployment. It will be possible, however, in some circumstances to deliver the branch stent 15 prior to the main stent 12. In such cases, the branch stent 15 will be deployed with the contacting portions 18 opened directly against the inner wall of the main blood vessel. The main stent 12 will then be positioned over the contacting portions 18 of the branch stent 15 and firmly expanded thereagainst. A sheath or expansion balloon can be used to properly align the side opening 16 of the main stent 12 with the opening within the contacting portion 18 of the branch stent 15.


In the embodiment shown in FIGS. 7-9, the main stent 40 with expandable portion 38 is positioned within the vessel 8 by the guidewires 20 (FIG. 7), and affixed in place by radial expansion of the main stent 40, most particularly by inflation of the balloon 25 (FIG. 8). The main stent is positioned so that the opening 16 is directly over the bifurcation point 50 in the subject vessels 7 and 8 (FIGS. 7 and 8). In order to aid such positioning, a side branch guidewire 36 and a stabilizing catheter 44 (as depicted in FIG. 7) are also inserted through the opening 16 of the main stent 40 and through the expandable portion 38 and into the branch vessel 7 (FIG. 8).


The optional expandable portion 38 of the main stent 40 is then expanded radially and in an at least partially perpendicular manner to the sides of the main stent side opening 16 (FIG. 8). In the embodiment illustrated in FIGS. 7 and 8, a balloon 25 is deployed along the side branch guidewire 36 through the expandable portion 38, and inflated until the expandable portion is fully expanded into the branch vessel 7 to cover the bifurcation point 50 of the branched vessel, as illustrated in FIG. 8. In order to extend the expandable portion 38 into the branch vessel 7, a balloon 25 disposed around a branch catheter 54 which is threaded along the side branch guidewire 36, through the main stent 40, through the opening 16 and expandable portion 38, and into the subject branch vessel 7 as shown in FIG. 8. The expandable portion 38 is then extended into the branch vessel 7 by inflation of the balloon 25, which pushes the expandable portion 38 outward radially and lateral to the side opening, into the branch vessel 7 (FIG. 8). Once all catheters and balloons are withdrawn, the expandable portion 38 is arrayed in lateral orientation to the sides of the opening 16 in the main stent 40, and surrounding the opening 16 into the vessel branch (FIG. 9). The guidewires 20 and 36 are then withdrawn from the main and branch vessels.


The expandable portion 38 is illustrated as a plurality of elements which are attached to the peripheral edge of the side opening 16. The elements project radially inwardly into the side opening and thus lie within the cylindrical envelope of the tubular main stent 40 prior to deployment, as shown in FIG. 7. The elements are opened by outward lateral deflection, typically using a balloon catheter, as illustrated in FIG. 8. The deflected elements both traverse the transition between the stent and the lumen of the branch vessel and also serve as an anchor for subsequent placement of the second stent.


In the double stent apparatus of FIG. 5 and in the main stent with expandable portion illustrated in FIGS. 7 and 9, the main stent as well as the expandable portions may be constructed at least partially of and/or coated or plated with an imagable material or marked with imagable markers 56 at suitable locations, including around the perimeter of the side openings of the main stent and at the ends of the expandable portions. In the differentially expandable stent structures of FIGS. 10-12 (described below), a distal portion may be radiopaque with the remainder being radiolucent. Suitable imagable materials are radiopaque, such as gold, tungsten, and the like.


When reinforcing a bifurcated vessel where both branches of the vessel require reinforcing, either 1) the single main stent with the expandable portion is used whereby the expandable portion extends into the vessel branch at least partly covering the origin of the bifurcation, which may be used alone or in combination with any conventional stent; or 2) the main stent without the expandable portion and at least one branch stent with contacting portion are used, the branch stent placed to extend through at least one side opening of the main stent into at least one branch vessel, wherein the branch stent is at least partially in registry and contacting the edge of the side opening through which it extends. The branch stent extends laterally at varying angles to the side opening of the main stent. When treating a bifurcated vessel where the area to he treated spans the bifurcation and unobstructed access to the unstented vessel is required, the main stent may be used either with or without the expandable portion, wherein at least one side opening is placed over the bifurcation point.


The stent apparatus of the invention may be constructed from any non-immunoreactive material, including but not limited to any of the materials disclosed in the prior art stents which are incorporated herein by reference. It is intended that the stent apparatuses of the invention may further be at least partially constructed of, or marked at certain points with, a material which may be imaged, most particularly but not limited to by x-ray and ultrasound.


The stents of the invention may be deployed according to known methods utilizing guidewires and catheters, which are then withdrawn from the subject following deployment of the stents. The subject stents may be self-expanding to conform to the shape of the vessel in which they are deployed, or they may be expanded utilizing balloon catheters, or by any other method currently known or developed in the future which is effective for expanding the stents of the invention. It is contemplated that prior to deployment the stents will be in a collapsed state, and will require either mechanical expansion (such as, for example, by balloon expansion) upon deployment or, for self-expanding stents, will require that the stent be confined to the catheter until deployment by, for instance, a retractable sheath, in which the sheath is removed during deployment and the stent self-dilated. The stents of the invention and the optional expandable portion of the main stent of the invention expand radially from their longitudinal axis, lateral to the side opening of the main stent. Other methods of dilation of the stents of the invention may exist, or may become available in the future, and such methods are contemplated as being within the scope of this invention. The stent 100 shown in FIG. 10 can also be described as having a first portion 110 comprising a plurality of serpentine rings 112 and a second portion 120 comprising a plurality of serpentine rings 122. Each serpentine ring 112, 122 has a plurality of elements that include struts 134 interconnected by turns. The plurality of serpentine rings 112 of the first portion 110 includes a plurality of first serpentine rings 112a and a second serpentine ring 112b. The second serpentine ring 112b has a first end which is engaged to the continuous band 104 at junction point 500a. The second serpentine ring 112b has a second end which is engaged to the continuous band 104 at junction point 500b. As shown in FIG. 10, the second portion 120 comprises a plurality of serpentine rings 122 which include a plurality of first serpentine rings 122a and a second serpentine ring 122b. The second serpentine ring 122b has a first end which is engaged to the continuous band 104 at junction point 500c. The second serpentine band 122b has a second end which is engaged to the continuous band 104 at junction point 500d.


Referring now to FIGS. 10-12, the present invention further provides stent structures having differential radial expansion characteristics. In particular, tubular stent structures having side holes, generally as described above, are configured so that a portion of the stent on one side of the side hole will expand at a different yield or threshold force than a portion of the stent on the other side of the side hole. Such different yield forces or pressures may be achieved in a variety of ways. For example, referring to FIG. 10, a stent 100 is illustrated in a “rolled out” view, i.e., the tubular stent is broken along an axial line and then rolled out in the resulting pattern shown in the Figure. The pattern shown in FIG. 10 is prior to expansion. The stent 100 includes a side hole 102 defined by a continuous band 104 having a plurality of loops 106 projecting into the open interior of the side hole. The loops 106 are an integral part of the band 104 and will, prior to expansion or opening, lie within the cylindrical envelope of the tubular body of the stent. The first portion 110 of the stent lies on one side of the side hole 102 and is defined by a plurality of serpentine rings 112. The serpentine rings are joined by axial expansion spring structures 114 so that the stent may be bent as it is introduced and/or deployed. A second portion 120 of the stent 100 is formed on the other side of side hole 102. The second portion is also defined by the plurality of serpentine rings 122 which are generally similar in structure to the rings 112 of the first portion 110. Each of the portions 110 and 120, however, include an axial spine 130 and 132. The axial spine 130 of the first portion 110 comprises simple W-shaped structures including outermost struts 134 which open at a relatively low expansion force on the adjoining hinge regions. In contrast, the axial spine 132 of the second portion 120 comprises box elements 138 which require a greater expansion force to open. Thus, in deployment, the first portion 110 will yield first to allow partial opening before the second portion 120 begins to open. The stent 200 shown in FIG. 11 can also be described as having a first portion 204 comprising a plurality of serpentine rings 208 and a second portion 206 comprising a plurality of serpentine rings 210. Each serpentine ring 208, 210 has a plurality of elements that include struts interconnected by turns. The plurality of serpentine rings 208 of the first portion 204 includes a plurality of first serpentine rings 208a and a second serpentine ring 208b. The second serpentine ring 208b has a first end which is engaged to the continuous band 104 at junction point 500a. The second serpentine ring 208b has a second end which is engaged to the continuous band 104 at junction point 500b. As shown in FIG. 11, the second portion 206 comprises a plurality of serpentine rings 210 which include a plurality of first serpentine rings 210a and a second serpentine ring 210b. The second serpentine ring 210b has a first end which is engaged to the continuous band 104 at junction point 500a. The second serpentine band 122b has a second end which is engaged to the continuous band 104 at junction point 500b.


A second stent structure 200 having differential expansion characteristics is illustrated in FIG. 11. A side hole 202 is formed from a continuous band of material, generally as described for FIG. 10. A first portion 204 and second portion 206 of the stent each comprise a plurality of serpentine ring structures 208 and 210, respectively. While the specific geometries differ, the structures of stents 100 and 200 are generally the same, except for axial spine portions 220 and 230 in the first portion 204 and second portion 206, respectively. The first spine portion 220 comprises a simple U-shaped loop having a pair of struts joined by a simple C-shaped hinge region. The spine 220 will thus open at relatively low expansion forces. In contrast, the axial spine 230 of the second portion 206 comprises a serpentine element which allows for axial expansion but does not permit radial expansion at all. Thus, the first portion 204 will begin opening at much lower expansion forces or pressures than will the second portion 206.


The stent 200 shown in FIG. 11 can also be described as having a plurality of serpentine rings 208, 210 comprising a plurality of struts 134 interconnected by turns 212. Each serpentine ring 208 is engaged to at least one other serpentine ring 208 and each serpentine ring 210 is engaged to at least one other serpentine ring 210. The serpentine rings 208, 210 each comprise a plurality of first struts 134a that have a first length and a plurality of second struts 134b that have a second length greater than the first length. The serpentine rings 208, 210 also each comprise a plurality of first turns 212a, second turns 212b, and third turns 212c. Each first turn 212a engages two first struts 134a, each second turn 212b engages two second struts 134b, and each third turn 212c engages one first strut 134a and one second strut 134b. As can be seen in FIG. 11, each first turn 212a is wider, has a greater circumferential extent, than a second turn 212b and the distance separating two first struts 212a is greater than the distance separating two second struts 212b. Also, in a serpentine ring, the first turns 212a are aligned with one another, the second turns 212b are aligned with one another, the third turns 212c are aligned with one another, and the first turns 212a are longitudinally offset from the second turns 212b. The first turns 212a and the second turns 212b of the serpentine bands 208 of the first portion 204 face in the same direction, towards the left end of the stent, while the third turns 212c face in the opposite direction, towards the right end of the stent. The serpentine rings 210 of the second portion 206 have an opposite orientation relative to the serpentine rings 208 of the first portion 204. Thus, for the second portion 206, the first turns 212a and the second turns 212b face in the same direction, to the right, and the third turns 212c face in the opposite direction, to the left. In addition to side hole 202, the stent also includes a plurality of first openings 214a and a plurality of second openings 214b. As shown in FIG. 11, the shape of the side hole 202 is different than the shape of the first openings 214a and the first openings 214a have a different shape than the second openings 214b.


A third concept for providing differential expansion is illustrated in FIG. 12. Stent 300 comprises a side hole 302 (which is shown in halves in the illustration), a first portion 304, and a second portion 306. The first portion 304 and second portion 306 each comprise serpentine rings 308 and 310, respectively. Differential expansion, however, is not achieved by providing a particular axial spine region, but rather by having different characteristics in the serpentine rings 308 and 310. The serpentine rings 308 have axially aligned struts joined by simple hinge regions. The length of the struts is relatively long (compared to those in the second portion 306 as described below) so that the rings will open at a lower expansion pressure or force. The serpentine rings 310 of the second portion 306 have relatively short axial struts defined by hinge regions each having two bands. Such structures require a greater expansion force than do the serpentine rings 308 of the first portion.


A fourth concept for providing a differential expansion stent is illustrated in FIGS. 14A and 14B. Stent 800 comprises a side hole 802 which is defined by parallel struts 804 and curved struts 806. Struts 804 can be expanded radially outwardly, forming a flap during stent expansion as illustrated schematically in FIG. 14B. Accordingly, struts 804 can be positioned to support the proximal section of a bifurcated vessel during stent expansion. As described above, portion 805 of stent 800 will preferentially expand at a different rate than portion 807 of stent 800.


A fifth differential expansion stent 900 is illustrated in FIG. 15. The stents shown in FIGS. 15-17 are examples of stents with side holes that are defined by a side branch member that has discontinuities. Stent 900 has a side hole 902 which is tear drop shaped, offering the advantage of easier expansion of the strut members 904 during differential expansion of the stent 900. The side branch member has two strut members 904 which are connected to one another by connectors 906. The strut members 904 are mirror images of one another. In this embodiment, the connectors 906 of the discontinuous side branch member have different configurations than the connectors 906 engaging adjacent circumferential rings of struts. As shown in FIG. 15 the discontinuous side branch member has two connectors 906 that have different configurations with one connector 906 being U shaped and one connector 906 being zig-zag. Due to the tear drop shape of the side hole 902 in this embodiment, the circumferential length of the side hole 902 varies from the proximal region of the side hole 902 to the distal region of the side hole 902.


A sixth differential expansion stent 920 that has a side opening 922 is shown in FIG. 16. Wavy bridges 924 connected to horizontal strut members 926 are adapted to provide superior flexibility in axial bending. Wavy bridges 928 around the perimeter of side opening 922 operate to provide axial flexibility about the side hole 922. Note that wavy bridges 924, 928 have substantially the same configuration. In this embodiment the discontinuous side branch member comprises at least two struts 926 and at least two connectors 906. As shown in FIG. 16, the side branch member has a first strut 926a, a second strut 926b, a third strut 926c, a fourth strut 926d, a fifth strut 926e, and a sixth strut 926f. The side branch member also has a first connector 906a, a second connector 906b, a third connector 906c, a fourth connector 906d, a fifth connector 906e, and a sixth connector 906f. As shown in FIG. 16, the connectors 906 of the side branch member can have substantially the same configurations or different configurations. For example, some of the connectors 906a-c, e-f are zig-zag, with some connectors have substantially the same zig-zag configuration, e.g. wavy bridges 928 and one connector 906a has a zig-zag configuration that is different from the other zig-zag configuration. Also, one connector 906d has a U-shaped configuration.


A seventh differential expansion stent 940 is shown in FIG. 17. Stent 940 has a side hole 942 which is oval in shape. In this embodiment, the discontinuous side branch member comprises four struts and four connectors 906a,b. Two of the struts being long struts 944 and two of the struts being long struts 946, with the pair of long struts 944 at one end of the side opening 942 and the other pair of long struts 946 at the opposite side of the side opening 942. The long struts 944 and 946 are curved and have a taper so that one end of the strut is wider than the other end of the strut. In this embodiment, the side branch member has two connectors 906 that have a zig-zag configuration and two connectors 906 that have a U-shaped configuration. The connectors 906 that have a zig-zag configuration are wavy bridges 948 which facilitate axial bending. In this embodiment, the two connectors 906 that have a zig-zag configuration are positioned opposite one another and the two connectors 906 that have a U-shaped configuration are positioned opposite one another at the ends of the side hole 942.


It will be appreciated that numerous other specific designs may be provided for differential expansion. What is important to the present invention, however, is that at least a portion of the stent on one side of the side hole, usually the entire length of the stent on that side of the hole, will be able to open prior to opening of the stent on the other side of the side hole. Preferably, the first portion of the stent will open at a balloon expansion pressure in the range from 1 atmospheres to 10 atmospheres, while the second portion of the stent will open in response to a balloon expansion pressure in the range from 2 atmospheres to 18 atmospheres.


Referring now to FIGS. 13A-13H, deployment of stent 100 will be described. While reference is made to stent 100, it will appreciated that the same method could be used as well with either of stents 200 or 300. Initially, a pair of guidewires GW1 and GW2 will be deployed in the lumen, typically a bifurcated blood vessel, so that guidewire GW1 extends through the main lumen of the main vessel past the ostium O of the branch vessel BRV. The second guidewire GW2 will be advanced through the lumen of the main vessel and into the lumen of the branch vessel BRV, as illustrated in FIG. 13A. The stent 100 will then be introduced over the guidewires on a delivery catheter 400 having an expansion balloon 402, where the stent is crimped over the expansion balloon. A sheath 404 is disposed in the second portion 120 of the stent with its distal tip (not shown) terminating immediately before the side opening 102. The assembly of the stent 100, delivery catheter 400, and sheath 404 will be delivered with the first guidewire GW1 passing through a guidewire lumen of catheter 400 and the second guidewire GW2 passing through the sheath 404, as illustrated in FIG. 13B. Initial alignment of the side hole 102 of stent 100 is achieved by advancing the stent so that the side hole lies close to the ostium O.


After an initial rough alignment is achieved, the balloon 402 is inflated to an initial inflation pressure which opens the first portion 110 but which leaves the second portion 120 in its substantially unexpanded configuration, as shown in FIG. 13C. Such partial opening allows the sheath 404 to be advanced over guidewire GW2 to better align the side hole with the branch vessel BRV, as shown in FIG. 13D. The sheath provides much greater stiffness than the guidewire, permitting manipulation of the partially deployed stent 100 to achieve the better alignment.


Referring now to FIG. 13E, after alignment is achieved, the balloon 402 will be inflated to a greater inflation pressure to open the second portion 120 of the stent 100 as well. A balloon catheter can then be advanced over the second guidewire GW2 so that balloon 502 can be expanded within the side opening 102 to open the loops 106, as illustrated in FIG. 13F. In many cases, this will be sufficient deployment for the stent where the loops provide the necessary anchoring and transition at the ostium O.


Optionally, a secondary stent 600 may be introduced as illustrated in FIGS. 13G and 13H. The stent 600 is introduced over a balloon 702 on balloon catheter 700. The final deployment configuration is illustrated in FIG. 13H.


It is intended that the invention include all modifications and alterations from the disclosed embodiments that fall within the scope of the claims of the invention.

Claims
  • 1. A stent, the stent comprising a plurality of first serpentine rings, each first serpentine ring comprising a plurality of first struts and a plurality of second struts, each first strut having a first length, each second strut having a second length, the second length being greater than the first length; each first serpentine ring further comprising a plurality of first turns and a plurality of second turns; each first turn engaging two first struts and each second turn engaging two second struts;one of the plurality of first serpentine rings forming an end of the stentwherein adjacent first serpentine rings engaged by a plurality of first connectors define a plurality of first openings having a first shape and a second opening having a second shape, the first shape being different than the second shape.
  • 2. The stent of claim 1, the stent having a first end, each first turn oriented towards the first end of the stent, and each second turn oriented towards the first end of the stent.
  • 3. The stent of claim 2, wherein the first turns are aligned with one another, the second turns are aligned with one another, and the first turns are offset from the second turns.
  • 4. The stent of claim 1, each first serpentine ring further comprising a plurality of third turns, each third turn engaging a first strut and a second strut.
  • 5. The stent of claim 1, each first turn and each second turn oriented in a first direction and each third turn oriented in a second direction, the first and second directions being opposite directions.
  • 6. The stent of claim 4, wherein the third turns are aligned with one another.
  • 7. The stent of claim 1, each first turn having a first circumferential extent and each second turn having a second circumferential extent, the first circumferential extent being greater than the second circumferential extent.
  • 8. The stent of claim 1, wherein a first distance separates two first struts engaged by a first turn and a second distance separates two second struts engaged by a second turn, the first distance being greater than the second distance.
  • 9. The stent of claim 1, adjacent first serpentine rings being engaged by a plurality of first connectors, each first connector extending between a first turn of one of the adjacent first serpentine rings and a first turn of the other of the adjacent first serpentine rings.
  • 10. The stent of claim 1, the stent further comprising a side hole defined by a continuous band having a plurality of loops.
  • 11. The stent of claim 10, the side hole having a third shape, the third shape being different than the first shape, and the third shape being different than the second shape.
  • 12. The stent of claim 1, the stent having a first end, the stent further comprising a plurality of second serpentine rings, each second serpentine ring comprising a plurality of first struts and a plurality of second struts, each first strut having a first length, each second strut having a second length, the second length being greater than the first length; each second serpentine ring further comprising a plurality of first turns and a plurality of second turns; each first turn engaging two first struts and each second turn engaging two second struts;each first turn of the first serpentine rings oriented towards the first end of the stent, and each second turn of the first serpentine rings oriented towards the first end of the stent;each first turn of the second serpentine rings oriented towards the second end of the stent, and each second turn of the second serpentine rings oriented towards the second end of the stent.
  • 13. The stent of claim 12, the plurality of first serpentine rings forming a first portion of the stent and the plurality of second serpentine rings forming a second portion of the stent.
  • 14. A stent having a first end and a second end, the stent comprising a plurality of serpentine bands, each serpentine band comprising a plurality of first struts and a plurality of second struts, each first strut having a first length, each second strut having a second length, the second length being greater than the first length; each serpentine band further comprising a plurality of first turns and a plurality of second turns; each first turn engaging two first struts, each second turn engaging two second struts,some of the plurality of serpentine bands orientated with each first turn oriented towards the first end of the stent, and each second turn oriented towards the first end of the stent and others of the plurality of serpentine bands oriented with each first turn oriented towards the second end of the stent and each second turn oriented towards the second end of the stent.
  • 15. A stent, the stent comprising a plurality of first serpentine bands, each first serpentine band comprising a plurality of first struts and a plurality of second struts, each first strut having a first length, each second strut having a second length, the second length being greater than the first length; each first serpentine band further comprising a plurality of first turns, a plurality of second turns, and a plurality of third turns; each first turn engaging two first struts and each second turn engaging two second struts; each third turn engaging one first strut and one second strutthe stent further comprising a side hole defined by a continuous band having a plurality of loops.
CROSS-REFERENCES TO RELATED APPLICATIONS

This application is a Continuation of application Ser. No. 12/472,189, filed May 26, 2009, which is a Continuation of application Ser. No. 11/545,254, filed Oct. 10, 2006, now U.S. Pat. No. 7,537,609, which is a Continuation of application Ser. No. 10/683,165, filed Oct. 14, 2003, now U.S. Pat. No. 7,118,593, which is a Continuation of application Ser. No. 09/963,114, filed on Sep. 24, 2001, now U.S. Pat. No. 6,706,062, which is a Continuation of application Ser. No. 09/326,445, filed on Jun. 4, 1999, now U.S. Pat. No. 6,325,826, which claims priority to Provisional Application No. 60/088,301, filed Jun. 5, 1998 and is a continuation-in-part of PCT application No. PCT/US99/00835, filed on Jan. 13, 1999, the contents of each of which are hereby incorporated by reference.

US Referenced Citations (476)
Number Name Date Kind
1596754 Moschelle Aug 1926 A
3657744 Ersek Apr 1972 A
3872893 Roberts Mar 1975 A
4140126 Choudhury Feb 1979 A
4309994 Grunwald Jan 1982 A
4410476 Redding et al. Oct 1983 A
4413989 Schjeldahl Nov 1983 A
4421810 Rasmussen Dec 1983 A
4453545 Inoue Jun 1984 A
4503569 Dotter Mar 1985 A
4552554 Gould et al. Nov 1985 A
4681570 Dalton Jul 1987 A
4689174 Lupke Aug 1987 A
4731055 Melinyshyn et al. Mar 1988 A
4733665 Palmaz Mar 1988 A
4739762 Palmaz Apr 1988 A
4759748 Reed Jul 1988 A
4762128 Rosenbluth Aug 1988 A
4769005 Ginsburg et al. Sep 1988 A
4769029 Patel Sep 1988 A
4774949 Fogarty Oct 1988 A
4819664 Nazari Apr 1989 A
4872874 Taheri Oct 1989 A
4878495 Grayzel Nov 1989 A
4896670 Crittenden Jan 1990 A
4900314 Quackenbush Feb 1990 A
4905667 Foerster et al. Mar 1990 A
4906244 Pinchuk et al. Mar 1990 A
4909258 Kuntz et al. Mar 1990 A
4957501 Lahille et al. Sep 1990 A
4957508 Kaneko et al. Sep 1990 A
4964850 Bouton et al. Oct 1990 A
4983167 Sahota Jan 1991 A
4994071 MacGregor Feb 1991 A
5042976 Ishitsu et al. Aug 1991 A
5054501 Chuttani et al. Oct 1991 A
5059177 Towne et al. Oct 1991 A
5061240 Cherian Oct 1991 A
5064435 Porter Nov 1991 A
5102403 Alt Apr 1992 A
5102417 Palmaz Apr 1992 A
5104404 Wolff Apr 1992 A
5117831 Jang Jun 1992 A
5122125 Deuss Jun 1992 A
5135536 Hillstead Aug 1992 A
5147317 Shank et al. Sep 1992 A
5159920 Condon et al. Nov 1992 A
5176617 Fischell et al. Jan 1993 A
5192297 Hull Mar 1993 A
5217440 Frassica Jun 1993 A
5244619 Burnham Sep 1993 A
5257974 Cox Nov 1993 A
5263932 Jang Nov 1993 A
5282472 Companion et al. Feb 1994 A
5304220 Maginot Apr 1994 A
5320605 Sahota Jun 1994 A
5324257 Osborne et al. Jun 1994 A
5337733 Bauerfeind et al. Aug 1994 A
5338300 Cox Aug 1994 A
5342295 Imran Aug 1994 A
5342297 Jang Aug 1994 A
5342387 Summers Aug 1994 A
5350395 Yock Sep 1994 A
5383892 Cardon et al. Jan 1995 A
5387235 Chuter Feb 1995 A
5395332 Ressemann et al. Mar 1995 A
5395334 Keith et al. Mar 1995 A
5404887 Prather Apr 1995 A
5409458 Khairkhahan et al. Apr 1995 A
5413581 Goy May 1995 A
5413586 Dibie et al. May 1995 A
5417208 Winkler May 1995 A
5437638 Bowman Aug 1995 A
5443497 Venbrux Aug 1995 A
5445624 Jimenez Aug 1995 A
5449373 Pinchasik et al. Sep 1995 A
5449382 Dayton Sep 1995 A
5456694 Marin et al. Oct 1995 A
5456712 Maginot Oct 1995 A
5456714 Owen Oct 1995 A
5458605 Klemm Oct 1995 A
5462530 Jang Oct 1995 A
5476471 Shifrin et al. Dec 1995 A
5487730 Marcadis et al. Jan 1996 A
5489271 Anderson Feb 1996 A
5489295 Piplani et al. Feb 1996 A
5496292 Burnham Mar 1996 A
5505702 Arney Apr 1996 A
5507768 Lau Apr 1996 A
5507769 Marin et al. Apr 1996 A
5514154 Lau et al. May 1996 A
5522801 Wang Jun 1996 A
5531788 Dibie et al. Jul 1996 A
5545132 Fagan et al. Aug 1996 A
5549553 Ressemann et al. Aug 1996 A
5549554 Miraki Aug 1996 A
5562620 Klein et al. Oct 1996 A
5562724 Vorwerk et al. Oct 1996 A
5562725 Schmitt et al. Oct 1996 A
5569295 Lam Oct 1996 A
5571087 Ressemann et al. Nov 1996 A
5575771 Walinsky Nov 1996 A
5575818 Pinchuk Nov 1996 A
5591228 Edoga Jan 1997 A
5593442 Klein Jan 1997 A
5607444 Lam Mar 1997 A
5609605 Marshall et al. Mar 1997 A
5609625 Piplani et al. Mar 1997 A
5609627 Goicoechea et al. Mar 1997 A
5609629 Fearnot et al. Mar 1997 A
5613949 Miraki Mar 1997 A
5613980 Chauhan Mar 1997 A
5613981 Boyle et al. Mar 1997 A
5617878 Taheri Apr 1997 A
5626600 Horzewski et al. May 1997 A
5628788 Pinchuk May 1997 A
5632762 Myler May 1997 A
5632763 Glastra May 1997 A
5632772 Alcime et al. May 1997 A
5634902 Johnson et al. Jun 1997 A
5639278 Derume et al. Jun 1997 A
5643340 Nunokawa Jul 1997 A
5653743 Martin Aug 1997 A
5662614 Edoga Sep 1997 A
5669924 Shaknovich Sep 1997 A
5669932 Fischell et al. Sep 1997 A
5676696 Morcade Oct 1997 A
5676697 McDonald Oct 1997 A
5679400 Tuch Oct 1997 A
5683450 Goicoechea et al. Nov 1997 A
5690642 Osborne et al. Nov 1997 A
5693084 Chutter Dec 1997 A
5693086 Goicoechea et al. Dec 1997 A
5697971 Fischell et al. Dec 1997 A
5707348 Krogh Jan 1998 A
5707354 Salmon Jan 1998 A
5709713 Evans et al. Jan 1998 A
5716365 Goicoechea et al. Feb 1998 A
5718683 Ressemann et al. Feb 1998 A
5718724 Goicoechea et al. Feb 1998 A
5720735 Dorros Feb 1998 A
5723004 Dereume et al. Mar 1998 A
5724977 Yock et al. Mar 1998 A
5728158 Lau et al. Mar 1998 A
5733303 Israel et al. Mar 1998 A
5735893 Lau et al. Apr 1998 A
5746766 Edoga May 1998 A
5749825 Fischell et al. May 1998 A
5749848 Jang et al. May 1998 A
5749890 Shaknovich May 1998 A
5755734 Richter et al. May 1998 A
5755770 Ravenscroft May 1998 A
5755771 Penn et al. May 1998 A
5755773 Evans May 1998 A
5755778 Kleshinski May 1998 A
5762631 Klein Jun 1998 A
5776101 Goy Jul 1998 A
5776161 Globerman Jul 1998 A
5776180 Goicoechea et al. Jul 1998 A
5782906 Marshall et al. Jul 1998 A
5800450 Lary et al. Sep 1998 A
5800508 Goicoechea et al. Sep 1998 A
5810872 Kanesaka et al. Sep 1998 A
5814061 Osborne et al. Sep 1998 A
5817126 Imran Oct 1998 A
5824008 Bolduc et al. Oct 1998 A
5824036 Lauterjung Oct 1998 A
5824040 Cox et al. Oct 1998 A
5824044 Quiachon et al. Oct 1998 A
5827320 Richter et al. Oct 1998 A
5833650 Imran Nov 1998 A
5836966 St. Germain Nov 1998 A
5837008 Berg et al. Nov 1998 A
5843031 Hermann et al. Dec 1998 A
5843160 Rhodes Dec 1998 A
5843164 Frantzen et al. Dec 1998 A
5846204 Solomon Dec 1998 A
5851210 Torossian Dec 1998 A
5851464 Davila et al. Dec 1998 A
5855600 Alt Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5865178 Yock Feb 1999 A
5868777 Lam Feb 1999 A
5871537 Holman et al. Feb 1999 A
5891133 Murphy-Chutorian Apr 1999 A
5893887 Jayaraman Apr 1999 A
5897588 Hull et al. Apr 1999 A
5906640 Penn et al. May 1999 A
5907893 Zadno-Azizi et al. Jun 1999 A
5913895 Burpee et al. Jun 1999 A
5913897 Corso et al. Jun 1999 A
5921958 Ressemann et al. Jul 1999 A
5922020 Klein et al. Jul 1999 A
5928248 Acker Jul 1999 A
5938682 Hojeibane Aug 1999 A
5938696 Goicoechea et al. Aug 1999 A
5948016 Jang Sep 1999 A
5951599 McCrory Sep 1999 A
5961548 Shmulewitz Oct 1999 A
5967986 Cimochowski et al. Oct 1999 A
5972017 Berg et al. Oct 1999 A
5972018 Israel et al. Oct 1999 A
6007517 Anderson Dec 1999 A
6013054 Jiun Yan Jan 2000 A
6013091 Ley et al. Jan 2000 A
6017324 Tu et al. Jan 2000 A
6017363 Hojeibane Jan 2000 A
6030414 Taheri Feb 2000 A
6033434 Borghi Mar 2000 A
6033435 Penn et al. Mar 2000 A
6036682 Lange et al. Mar 2000 A
6039749 Marin et al. Mar 2000 A
6042597 Kveen et al. Mar 2000 A
6045557 White et al. Apr 2000 A
6048361 Von Oepen Apr 2000 A
6056775 Borghi et al. May 2000 A
6059823 Holman et al. May 2000 A
6059824 Taheri May 2000 A
6066168 Lau et al. May 2000 A
6068655 Seguin et al. May 2000 A
6071285 Lashinski et al. Jun 2000 A
6086611 Duffy et al. Jul 2000 A
6090127 Globerman Jul 2000 A
6090128 Douglas Jul 2000 A
6093203 Uflacker Jul 2000 A
6096073 Webster et al. Aug 2000 A
6099497 Adams et al. Aug 2000 A
6113579 Eidenschink et al. Sep 2000 A
6117117 Mauch Sep 2000 A
6117156 Richter et al. Sep 2000 A
6129738 Lashinski et al. Oct 2000 A
6129754 Kanesaka et al. Oct 2000 A
6142973 Carleton et al. Nov 2000 A
6143002 Vietmeier Nov 2000 A
6152945 Bachinski et al. Nov 2000 A
6159238 Killion et al. Dec 2000 A
6165195 Wilson et al. Dec 2000 A
6165197 Yock Dec 2000 A
6168621 Vrba Jan 2001 B1
6179867 Cox Jan 2001 B1
6183506 Penn et al. Feb 2001 B1
6183509 Dibie Feb 2001 B1
6190403 Fischell et al. Feb 2001 B1
6203568 Lombardi et al. Mar 2001 B1
6203569 Wijay Mar 2001 B1
6210380 Mauch Apr 2001 B1
6210429 Vardi Apr 2001 B1
6210433 Larre Apr 2001 B1
6217527 Selmon et al. Apr 2001 B1
6217608 Penn et al. Apr 2001 B1
6221080 Power Apr 2001 B1
6221090 Wilson Apr 2001 B1
6221098 Wilson et al. Apr 2001 B1
6231563 White et al. May 2001 B1
6231598 Berry et al. May 2001 B1
6231600 Zhong May 2001 B1
6235051 Murphy May 2001 B1
6241762 Shanley Jun 2001 B1
6254593 Wilson Jul 2001 B1
6258073 Mauch Jul 2001 B1
6258099 Mareiro et al. Jul 2001 B1
6258115 Dubrul Jul 2001 B1
6258116 Hjeibane Jul 2001 B1
6258121 Yang et al. Jul 2001 B1
6261273 Ruiz Jul 2001 B1
6261305 Marotta et al. Jul 2001 B1
6261316 Shaolian et al. Jul 2001 B1
6261319 Kveen et al. Jul 2001 B1
6264662 Lauterjung Jul 2001 B1
6264682 Wilson et al. Jul 2001 B1
6264686 Rieu et al. Jul 2001 B1
6264688 Herklotz et al. Jul 2001 B1
6273911 Cox et al. Aug 2001 B1
6273913 Wright et al. Aug 2001 B1
6287314 Lee et al. Sep 2001 B1
6290673 Shanley Sep 2001 B1
6293967 Shanley Sep 2001 B1
6293968 Taheri Sep 2001 B1
6299634 Bergeron Oct 2001 B1
6302906 Goicoechea et al. Oct 2001 B1
6309412 Lau et al. Oct 2001 B1
6309414 Rolando et al. Oct 2001 B1
6312459 Huang et al. Nov 2001 B1
6325821 Gashino et al. Dec 2001 B1
6325822 Chouinard Dec 2001 B1
6325826 Vardi et al. Dec 2001 B1
6330884 Kim Dec 2001 B1
6334864 Amplatz et al. Jan 2002 B1
6334870 Ehr et al. Jan 2002 B1
6346089 Dibie et al. Feb 2002 B1
6355060 Lenker et al. Mar 2002 B1
6361544 Wilson et al. Mar 2002 B1
6361555 Wilson Mar 2002 B1
6383213 Wilson et al. May 2002 B2
6383215 Sass May 2002 B1
6387120 Wilson et al. May 2002 B2
6395018 Castaneda May 2002 B1
6398792 O'Connor Jun 2002 B1
6398804 Spielberg Jun 2002 B1
6428570 Globerman Aug 2002 B1
6432133 Lau et al. Aug 2002 B1
6436104 Hojeibane Aug 2002 B2
6436134 Richter et al. Aug 2002 B2
6478816 Kveen et al. Nov 2002 B1
6482211 Choi Nov 2002 B1
6485511 Lau et al. Nov 2002 B2
6494905 Zedler et al. Dec 2002 B1
6508836 Wilson et al. Jan 2003 B2
6511504 Lau et al. Jan 2003 B1
6511505 Cox et al. Jan 2003 B2
6517558 Gittings et al. Feb 2003 B2
6520988 Clombo et al. Feb 2003 B1
6527799 Shanley et al. Mar 2003 B2
6540719 Bigus et al. Apr 2003 B2
6540779 Richter et al. Apr 2003 B2
6572647 Supper Jun 2003 B1
6579309 Loos et al. Jun 2003 B1
6579312 Wilson et al. Jun 2003 B2
6582394 Reiss et al. Jun 2003 B1
6582459 Lau et al. Jun 2003 B1
6596020 Vardi et al. Jul 2003 B2
6596022 Lau et al. Jul 2003 B2
6599316 Vardi et al. Jul 2003 B2
6645242 Quinn Nov 2003 B1
6689156 Davidson et al. Feb 2004 B1
6692483 Vardi et al. Feb 2004 B2
6695877 Brucker et al. Feb 2004 B2
6706062 Vardi et al. Mar 2004 B2
6749628 Cho et al. Jun 2004 B1
6776793 Brown et al. Aug 2004 B2
6786922 Schaeffer Sep 2004 B2
6811566 Penn et al. Nov 2004 B1
6818014 Brown et al. Nov 2004 B2
6835203 Vardi et al. Dec 2004 B1
6858038 Heuser Feb 2005 B2
6884258 Vardi et al. Apr 2005 B2
6896699 Wilson et al. May 2005 B2
6929660 Ainsworth et al. Aug 2005 B1
6932837 Amplatz et al. Aug 2005 B2
6955687 Richter et al. Oct 2005 B2
6955688 Wilson et al. Oct 2005 B2
6962602 Vardi et al. Nov 2005 B2
7018400 Lashinski et al. Mar 2006 B2
7056323 Mareiro et al. Jun 2006 B2
7060091 Killion et al. Jun 2006 B2
7118593 Davidson et al. Oct 2006 B2
7204848 Brown et al. Apr 2007 B1
7220275 Davidson et al. May 2007 B2
7335228 Schaeffer Feb 2008 B2
7341598 Davidson et al. Mar 2008 B2
D568476 Cottone et al. May 2008 S
7534258 Gomez et al. May 2009 B2
7537609 Davidson et al. May 2009 B2
7632305 Broome et al. Dec 2009 B2
7678142 Vardi et al. Mar 2010 B2
7771462 Davidson et al. Aug 2010 B1
7837726 Von Oepen et al. Nov 2010 B2
7892279 Davidson et al. Feb 2011 B2
8114146 Brown et al. Feb 2012 B2
20010003161 Vardi et al. Jun 2001 A1
20010004706 Hojeibane Jun 2001 A1
20010004707 Dereurne et al. Jun 2001 A1
20010012927 Mauch Aug 2001 A1
20010016766 Vardi et al. Aug 2001 A1
20010016767 Wilson et al. Aug 2001 A1
20010016768 Wilson et al. Aug 2001 A1
20010025195 Shaolian et al. Sep 2001 A1
20010027291 Shanley Oct 2001 A1
20010027338 Greenberg Oct 2001 A1
20010029396 Wilson et al. Oct 2001 A1
20010037116 Wilson et al. Nov 2001 A1
20010037137 Vardi et al. Nov 2001 A1
20010037138 Wilson et al. Nov 2001 A1
20010037146 Lau et al. Nov 2001 A1
20010037147 Lau et al. Nov 2001 A1
20010039395 Mareiro et al. Nov 2001 A1
20010039448 Dibie Nov 2001 A1
20010047201 Cox et al. Nov 2001 A1
20010049552 Richter et al. Dec 2001 A1
20010056297 Hojeibane Dec 2001 A1
20020013618 Marotta et al. Jan 2002 A1
20020013619 Shanley Jan 2002 A1
20020022874 Wilson Feb 2002 A1
20020026232 Marrotta et al. Feb 2002 A1
20020032478 Bockstegers et al. Mar 2002 A1
20020035392 Wilson Mar 2002 A1
20020042650 Vardi et al. Apr 2002 A1
20020052648 McGuckin et al. May 2002 A1
20020058990 Jang May 2002 A1
20020072790 McGuckin et al. Jun 2002 A1
20020107564 Cox et al. Aug 2002 A1
20020111672 Kim et al. Aug 2002 A1
20020111675 Wilson Aug 2002 A1
20020123790 White et al. Sep 2002 A1
20020123791 Harrison Sep 2002 A1
20020123797 Majercak Sep 2002 A1
20020123798 Burgermeister Sep 2002 A1
20020151959 Von Oepen Oct 2002 A1
20020156516 Vardi et al. Oct 2002 A1
20020156517 Perouse Oct 2002 A1
20020165604 Shanley Nov 2002 A1
20020173835 Bourang et al. Nov 2002 A1
20020173840 Brucker et al. Nov 2002 A1
20020177892 Globerman Nov 2002 A1
20020183763 Callol et al. Dec 2002 A1
20020193872 Trout et al. Dec 2002 A1
20020193873 Brucker et al. Dec 2002 A1
20020198593 Gomez et al. Dec 2002 A1
20030004535 Musbach et al. Jan 2003 A1
20030009209 Hojeibane Jan 2003 A1
20030009214 Shanley Jan 2003 A1
20030014102 Hong et al. Jan 2003 A1
20030023301 Cox et al. Jan 2003 A1
20030028233 Vardi et al. Feb 2003 A1
20030050688 Fischell et al. Mar 2003 A1
20030055378 Wang et al. Mar 2003 A1
20030055483 Gumm Mar 2003 A1
20030074047 Richter Apr 2003 A1
20030093109 Mauch May 2003 A1
20030097169 Brucker May 2003 A1
20030114912 Sequin et al. Jun 2003 A1
20030114915 Mareiro et al. Jun 2003 A1
20030125791 Sequin et al. Jul 2003 A1
20030125799 Limon et al. Jul 2003 A1
20030125802 Callol et al. Jul 2003 A1
20030135259 Simson Jul 2003 A1
20030181923 Vardi Sep 2003 A1
20030195606 Davidson et al. Oct 2003 A1
20040006381 Sequin et al. Jan 2004 A1
20040015225 Kim et al. Jan 2004 A1
20040015227 Vardi et al. Jan 2004 A1
20040044396 Clerc et al. Mar 2004 A1
20040059406 Cully et al. Mar 2004 A1
20040088007 Eidenschink May 2004 A1
20040117003 Ouriel et al. Jun 2004 A1
20040133268 Davidson et al. Jul 2004 A1
20040138732 Suhr et al. Jul 2004 A1
20040138737 Davidson et al. Jul 2004 A1
20040148006 Davidson et al. Jul 2004 A1
20040172121 Eidenschink et al. Sep 2004 A1
20040186560 Alt Sep 2004 A1
20040225345 Fischell et al. Nov 2004 A1
20040267352 Davidson et al. Dec 2004 A1
20050004656 Das Jan 2005 A1
20050010278 Vardi et al. Jan 2005 A1
20050015108 Williams et al. Jan 2005 A1
20050015135 Shanley Jan 2005 A1
20050060027 Khenansho et al. Mar 2005 A1
20050096726 Sequin et al. May 2005 A1
20050102021 Osborne May 2005 A1
20050102023 Yadin et al. May 2005 A1
20050119731 Brucker et al. Jun 2005 A1
20050125076 Ginn Jun 2005 A1
20050131526 Wong Jun 2005 A1
20050149161 Eidenschink et al. Jul 2005 A1
20050154442 Eidenschink et al. Jul 2005 A1
20050154444 Quadri Jul 2005 A1
20050183259 Eidenschink et al. Aug 2005 A1
20050209673 Shaked Sep 2005 A1
20050228483 Kaplan et al. Oct 2005 A1
20060036315 Yadin et al. Feb 2006 A1
20060041303 Israel Feb 2006 A1
20060079956 Eigler et al. Apr 2006 A1
20060085061 Vardi et al. Apr 2006 A1
20060173528 Feld et al. Aug 2006 A1
20060241740 Vardi et al. Oct 2006 A1
20070032855 Davidson et al. Feb 2007 A1
20070073376 Krolik et al. Mar 2007 A1
20070203571 Kaplan et al. Aug 2007 A1
20070208414 Sorenson et al. Sep 2007 A1
20070260303 Hegg Nov 2007 A1
20080132997 Venturelli Jun 2008 A1
20090012596 Kocur Jan 2009 A1
20090012599 Broome et al. Jan 2009 A1
20090319030 Yadin Dec 2009 A1
20100070023 Broome et al. Mar 2010 A1
Foreign Referenced Citations (131)
Number Date Country
2220864 Jul 1997 CA
2318314 Jul 1999 CA
9014845 Feb 1991 DE
29701758 Mar 1997 DE
29701883 Mar 1997 DE
0347023 Dec 1989 EP
0479730 Apr 1995 EP
684022 Nov 1995 EP
804907 Nov 1997 EP
0751752 Jun 1998 EP
0479557 Jul 1998 EP
876805 Nov 1998 EP
0880949 Dec 1998 EP
884028 Dec 1998 EP
891751 Jan 1999 EP
0895759 Feb 1999 EP
897698 Feb 1999 EP
897700 Feb 1999 EP
904745 Mar 1999 EP
0937442 Aug 1999 EP
968689 Jan 2000 EP
1031329 Feb 2000 EP
0783873 Apr 2000 EP
1031328 Aug 2000 EP
1031330 Aug 2000 EP
0883384 Dec 2000 EP
0862392 Aug 2001 EP
0808140 Dec 2001 EP
1190685 Mar 2002 EP
1157674 Jul 2005 EP
1070513 Jun 2006 EP
2678508 Jan 1993 FR
2740346 Apr 1997 FR
2756173 May 1998 FR
2337002 Nov 1999 GB
8806026 Aug 1988 WO
9013332 Nov 1990 WO
9112779 Sep 1991 WO
9219308 Nov 1992 WO
9521592 Aug 1995 WO
9629955 Oct 1996 WO
9634580 Nov 1996 WO
9641592 Dec 1996 WO
9707752 Mar 1997 WO
9709948 Mar 1997 WO
9715346 May 1997 WO
9716217 May 1997 WO
9726936 Jul 1997 WO
9733532 Sep 1997 WO
9741803 Nov 1997 WO
9745073 Dec 1997 WO
9746174 Dec 1997 WO
9817204 Apr 1998 WO
9819628 May 1998 WO
9835634 Aug 1998 WO
9836709 Aug 1998 WO
9837833 Sep 1998 WO
9844871 Oct 1998 WO
9847447 Oct 1998 WO
9848733 Nov 1998 WO
9848879 Nov 1998 WO
9852497 Nov 1998 WO
9903426 Jan 1999 WO
9904726 Feb 1999 WO
9915103 Apr 1999 WO
9915109 Apr 1999 WO
9917680 Apr 1999 WO
9924104 May 1999 WO
9934749 Jul 1999 WO
9936002 Jul 1999 WO
9936015 Jul 1999 WO
9939681 Aug 1999 WO
9944539 Sep 1999 WO
9956661 Nov 1999 WO
9958059 Nov 1999 WO
9965419 Dec 1999 WO
0000104 Jan 2000 WO
0007523 Feb 2000 WO
0010489 Mar 2000 WO
0012166 Mar 2000 WO
0013613 Mar 2000 WO
0016719 Mar 2000 WO
0027307 May 2000 WO
0027463 May 2000 WO
0028922 May 2000 WO
0044307 Aug 2000 WO
0044309 Aug 2000 WO
0047134 Aug 2000 WO
0048531 Aug 2000 WO
0049951 Aug 2000 WO
0051523 Sep 2000 WO
0053122 Sep 2000 WO
0057813 Oct 2000 WO
0067673 Nov 2000 WO
0071054 Nov 2000 WO
0071055 Nov 2000 WO
0074595 Dec 2000 WO
0121095 Mar 2001 WO
0121109 Mar 2001 WO
0121244 Mar 2001 WO
0135715 May 2001 WO
0135863 May 2001 WO
0139697 Jun 2001 WO
0139699 Jun 2001 WO
0141677 Jun 2001 WO
0143665 Jun 2001 WO
0143809 Jun 2001 WO
0145594 Jun 2001 WO
0145785 Jun 2001 WO
0149342 Jul 2001 WO
0154621 Aug 2001 WO
0154622 Aug 2001 WO
0158385 Aug 2001 WO
0160284 Aug 2001 WO
0170294 Sep 2001 WO
0170299 Sep 2001 WO
0174273 Oct 2001 WO
0189409 Nov 2001 WO
0200138 Jan 2002 WO
02053066 Jul 2002 WO
02076333 Oct 2002 WO
02088012 Nov 2002 WO
02094336 Nov 2002 WO
03007842 Jan 2003 WO
03055414 Jul 2003 WO
03063924 Aug 2003 WO
2004026174 Apr 2004 WO
2004026180 Apr 2004 WO
2005009295 Feb 2005 WO
2005014077 Feb 2005 WO
2006028925 Mar 2006 WO
Related Publications (1)
Number Date Country
20110153002 A1 Jun 2011 US
Provisional Applications (1)
Number Date Country
60088301 Jun 1998 US
Continuations (5)
Number Date Country
Parent 12472189 May 2009 US
Child 13020585 US
Parent 11545254 Oct 2006 US
Child 12472189 US
Parent 10683165 Oct 2003 US
Child 11545254 US
Parent 09963114 Sep 2001 US
Child 10683165 US
Parent 09326445 Jun 1999 US
Child 09963114 US
Continuation in Parts (1)
Number Date Country
Parent PCT/US99/00835 Jan 1999 US
Child 09326445 US